The EU boosts Ebola researchOctober 24, 2014
Hat: European Union to boost Ebola research with 24.4 million euro
Funding Scheme: 2014-10-23
Pgm2014 2020: Yes
The European Commission has today announced €24.4 million from the EU budget for urgently needed Ebola research.
The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation programme, will be provided via a fast-track procedure in order to start work as soon as possible.The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative.
The funding will be provided following proposals from teams across the EU and in numerous 3rd countries, which were evaluated by an independent group of experts (see annex for chosen projects).
The Commission has also asked the European and Developing Countries Clinical Trials Partnership (EDCTP) to include emerging epidemics of concern to Africa, including Ebola, in its work plan. This will allow EDCTP to fund clinical trials on drugs, vaccines and diagnostics in upcoming calls.
The announcement comes as the WHO hosts a high level meeting in Geneva today, involving the international community and industry representatives. The meeting is to discuss access to near-term vaccines, the financing of vaccine and immunisation campaigns and the design, production capacity, regulation and indemnity of clinical trials.
The European Union has been active from the early stages of the crisis. The European Commission alone has so far pledged €180 million of humanitarian and development aid to help the countries affected by the epidemic. This is done, for instance, by providing immediate healthcare to the affected communities and helping contain the spread of the epidemic through rapid diagnosis and disease awareness campaigns. Besides financial aid, the EU is also contributing to fight the epidemic with experts’ presence on the ground and coordination for the delivery of supplies and possible evacuations.
The Commission is already funding research addressing Ebola under the EU’s Seventh Framework Programme (FP7) for Research and Development: on the development of new antiviral drugs, on linking up high-security laboratories, on the clinical management of patients particularly in Europe, and on solutions to ethical, administrative, regulatory and logistical bottlenecks that prevent a rapid research response.
Url description: European Commission press agency
Url info description: http://europa.eu/rapid/press-release_IP-14-1194_en.htm